New Era Capital Partners closes $140M to turn Israeli startups into ‘global citizens’. For founders who want to work with people like them, New Era Capital Partners will fit that bill.
ESG in Venture Capital: A Knowledge Round-up for Israeli VCs and Startups
We are proud to share New Era Capital Partners’ first white paper, ESG in Venture Capital. The paper tackles an emerging field of practice within venture capital that has torpedoed to the top of the global agenda, namely, the inclusion of environmental, social, and governance (ESG) considerations within investment process and their integration within the commercial activities of portfolio companies.
Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding
Variantyx, a technology-driven precision medicine company providing advanced genomic testing for the rare genetic disorders, reproductive health, and precision oncology markets, announced they have secured $41.5M series C-2 funding round, led by New Era Capital Partners.
Neosec, an API security startup, emerges from stealth with $20.7M
Neosec, a cybersecurity platform designed to secure APIs, today emerged from stealth with $20.7 million in series A funding from True Ventures, New Era Capital Partners, TLV, SixThirty, and several angel investors. According to CEO Giora Engel, the proceeds will be put toward product development and growing Neosec’s business in the U.S., Europe, the Middle East, and Asia.
Papaya Global valuation surges to $3.7 billion on back of $250 million Series D
The Israeli company’s valuation has increased by 10x since September 2020. "I believe that this is our final funding round before going public, but in today's market everything is fluid," revealed CEO Eynat Guez
.jpg)
